Quantcast Mike Terretti's Daily Pharma News
Mike Terretti's Daily Pharma News By Mike Terretti 919-781-0400x112
Mike Terretti’s focus is the Pharmaceutical and Biotechnology Industries in Executive Recruitment. THe following information drives all the growth and opportunity in our market.
Mike Terretti's Daily Pharma News >> PHARMACEUTICAL INDUSTRY November 21, 2009 members login here
Public San Francisco -Global Clinical Research -Oncology 
My Public San Francisco area client is focused on the development and commercialization of novel therapeutics for oncology.
This position in the overall management of the clinical project team and with the development of clinical plans and implementation of clinical trials.
Executive Director, Global Clinical Research and Development-Oncology

Essential functions include, but are not limited to the following:
• Oversee... Read More    Add Comment

More
>>  PHARMACEUTICAL INDUSTRY
EDITORIAL: Promises of drug industry fall flat: AS PRICES INCREASE, CONGRESS LOSES
BusinessWeek - 4 Hours ago
11/21/2009 8:48 AM ET 11/21/2009 8:31 AM ET Nov. 21--Is the support of the pharmaceutical industry needed for Congress to pass health care reform? Or is the price of that support too high for the people
     Add Comment

Merck Presents Phase IIb Study Results at AHA Annual Scientific S...
Zibb - 16 Hours ago
Company: Merck & Co., Inc. (MRK) In a phase IIb study in 589 patients with primary hypercholesterolemia or mixed hyperlipidemia treated with anacetrapib as monotherapy or co-administered with atorvastatin,
Merck Presents Phase IIb Study Results at AHA Annual Scientific Sessions TradingMarkets
Aegera commences Phase IIb study of AEG35156 for treatment of acute myeloid leukemia Pharmacy Choice
all 2 news articles >>      Add Comment

Covidien says FDA extends review of opiod pain drug
Reuters Health - 20 Hours ago
-0400 (Reuters Health) * FDA sets Feb. 22, 2010, as new action date * Says FDA needs more time to review additional data BANGALORE (Reuters) - Covidien Plc said U.S. health regulators extended the review
FDA Extends NDA Review for Neuromed Pharmaceuticals's Exalgo(TM) Extended-Release BioSpace
Covidien: FDA Extends Review of Opioid Pain Drug FDA News
all 2 news articles >>      Add Comment

Roche's Actemra successful in arthritis study
Reuters Health - 20 Hours ago
-0400 (Reuters Health) * Improves symptoms of sJIA after 12 weeks of therapy * Meets primary endpoint in phase III study * EMA rules against Avastin use for aggressive brain cancer * Stock up 0.1 pct
Roche (RHHBY)'s (JOBS) Actemra Successful in Arthritis Study; Meets Primary Endpoint BioSpace
Rocheâ??s Actemra Successful in Arthritis Study FDA News
all 7 news articles >>      Add Comment

FDA Approves Bristol-Myers' Abilify To Treat Irritabilty In Pediatric Patients With
RTTNews.com - 20 Hours ago
(RTTNews) - Biopharmaceutical company Bristol-Myers Squibb Co. (BMY: News ) and Otsuka Pharmaceutical Co., Ltd. said Friday that U.S. Food and Drug Administration or FDA has approved the supplemental
     Add Comment

Drug firms’ tired song and dance on reform
Boston Globe - 78 Minutes ago
IN MAKING a fool of President Obama, Big Pharma has turned itself into a poison pill of health care reform. In the summer, the drug companies offered $8 billion a year over 10 years in drug cost cuts,
Drug firms tired song and dance on reform Boston Globe
all 1 news articles >>      Add Comment

The Worlds Largest Earthquake-Safe Building
Gizmodo - 2 Hours ago
The new terminal at Istanbul's Sabiha Gken Airport is the world's largest earthquake-safe building. You're looking at the over two million square feet of scaffolding that support it, all resting on top
Istanbul Opens Worldâ??s Largest Earthquake-Safe Building Wired News
World's Largest Earthquake-Safe Building Wired News
all 4 news articles >>      Add Comment

Bringing Pfizer to New London came at a heavy cost to taxpayers: But some say company's
TradingMarkets - 5 Hours ago
(The Day - McClatchy-Tribune Information Services via COMTEX) -- PFE | Quote | Chart | News | PowerRating -- It took a lot more than the promise of spiffed-up surroundings and the desire of a top executive
     Add Comment

Ironwood Pharmaceuticals plans IPO
Boston Globe - 6 Hours ago
Ironwood Pharmaceuticals, a Cambridge biotechnology company developing a treatment for irritable bowel syndrome, yesterday filed plans to go public.
     Add Comment

Ligand receives US$ 2 mn milestone payments from Merck for research pact
PharmaBiz - 10 Hours ago
Ligand Pharmaceuticals Incorporated has received US$ 2 million in milestone payments from N V Organon, a subsidiary of Merck & Co, Inc, stemming from its research collaboration that is due to expire at
Ligand Earns $2 Million Merck Milestone Contract Pharma
Ligand wins $2 million milestone payments from NV Organon - Zibb.... Zibb
all 9 news articles >>      Add Comment

Flu season, ailing economy aiding Michigan drug maker
Grand Haven Tribune - 14 Hours ago
ALLEGAN Record profits. Job openings. Shareholders making money. It's not what you might think in Michigan, home to the country's highest unemployment rate, but a century-old company is in robust health
Flu season, ailing economy aiding Mich. drug maker Battle Creek Enquirer
all 1 news articles >>      Add Comment

AstraZeneca Submits New Heart Drug Application
Pharmaceutical Technology - 16 Hours ago
AstraZeneca has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for ticagrelor, a novel new treatment for cardiac events in patients with acute coronary syndrome. This
AstraZeneca Submits US New Drug Application for Brilinta (Ticagrelor), an Investigational PharmiWeb
AstraZeneca Submits US New Drug Application for Brilinta , an Investigational Antiplatelet PharmaceuticalProcessing
all 4 news articles >>      Add Comment

Genentech & Biogen Idec get complete response letter from US FDA for Rituxan to
PharmaBiz - 17 Hours ago
Genentech, Inc, a wholly-owned member of the Roche Group and Biogen Idec announced that the US Food and Drug Administration (FDA) issued a complete response on the companies' applications for Rituxan
     Add Comment

PolyMedix Secures $20.7 Million Equity Financing
TradingMarkets - 17 Hours ago
(Close-Up Media via COMTEX) -- PYMX | Quote | Chart | News | PowerRating -- PolyMedix Inc., a biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular
Starpharma secures A$15.6 million in financing Individual.com
all 1 news articles >>      Add Comment

Big Pharma Mergers: Good News Or Bad?
Investors Business Daily - 19 Hours ago
Whoever says you can't throw money at problems hasn't spent much time following the Big Pharma sector this year. More than $160 billion worth of buyouts involving top drugmakers has already been inked
     Add Comment

FDA Takes Action Against Dairy Farm and Owner
Iowa Ag Connection - 19 Hours ago
Judge Marvin J. Garbis of the United States District Court for the District of Maryland entered a Consent Decree of Permanent Injunction (Decree) against Old Carolina Farm and its owner, Francis Roderick,
Medical News: FDA Takes Action Against Maryland Veal Calf Dealer BioFind
FDA takes action against Maryland veal calf dealer Dairy Herd
all 3 news articles >>      Add Comment

Glaxo recalls vaccine lot over allergic reactions
CTV.ca - 20 Hours ago
CTV News Video More than 100,000 doses of the H1N1 vaccine were withdrawn on Thursday after a number of people who got the shot suffered a potentially deadly allergic reaction. Manitoba's Chief Medical
GSK Recalls One Lot of H1N1 Vaccine Over Anaphylaxis Concerns FDA News
all 1 news articles >>      Add Comment

Ironwood Pharmaceuticals Files Registration Statement for Initial Public Offering
Fort Mills Times - 5 Hours ago
CAMBRIDGE, Mass. -- today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering of shares
Fabrinet Files Registration Statement for an Initial Public Offering Individual.com
Calix Networks Files for $100 Million IPO Private Equity HUB
all 8 news articles >>      Add Comment

Pharmaceutical Manufacturer Fills Prescription for DEACOM ERP Software
24-7PressRelease.com - 3 Hours ago
/24-7PressRelease/ -- Deacom, Inc. (www.deacom.net) today announced Supplemental Manufacturing and Ingredients, LLC ('SMI'), a manufacturer of dietary and nutritional supplements based in Tempe, Ariz.,
     Add Comment

The FDA Targets Websites Over Drug Sales
WebProNews - 2 Hours ago
FDA says drug sites could be shuttered The Food and Drug Administration is cracking down on 136 websites it says were selling illegal or misbranded drugs to U.S. consumers. The FDA says none of the websites
     Add Comment

Female Viagra not as pink as it's painted
Stv.tv - 3 Hours ago
The Write Factor: Marty McMahon warns not to be surprised if the ladies do not stand up for a female version of Viagra quite as enthusiastically as the gentlemen have for theirs. 138446 Sex and the City
     Add Comment

::: FDA Extends NDA Review for Exalgo Extended-Release Tablets
Biotech Intelligence - 3 Hours ago
CAMBRIDGE, Mass. & VANCOUVER, British Columbia--(BUSINESS WIRE)--CombinatoRx, Incorporated (NASDAQ: CRXX) and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced
FDA Extends NDA Review for Exalgo(TM) Extended-Release Tablets Individual.com
FDA Extends Review of NDA for Exalgo SmartBrief
all 20 news articles >>      Add Comment

ExL Pharma's Leading European Digital Marketing and Public ...
Ulitzer - 4 Hours ago
NEW YORK, NY -- (Marketwire) -- 11/18/09 -- Bayer Schering Pharma and ExL Pharma today announced that the 2nd Annual Digital Pharma Europe and 2nd Annual European Public Relations and Communications Summit
     Add Comment

Pfizer to pay $8.8m to patient
Asiaone - 4 Hours ago
LOS ANGELES, USA- A Philadelphia jury on Friday ordered pharmaceutical giant Pfizer (PFE.N) to pay US$6.3 million ($8.8 million) in compensatory damages to an Illinois breast cancer survivor after finding
Pfizer to pay $6.3 mln to patient in Prempro lawsuit Interactive Investor International
all 1 news articles >>      Add Comment

Failed anti-depressant drug could be 'women's Viagra'
Asiaone - 4 Hours ago
WASHINGTON - A drug that failed to fight the blues could be the female answer to the little blue pill Viagra, the lead North American investigator analysing tests of the drug said Tuesday. Women who took
Failed anti-depressant is 'women's Viagra' Daily Telegraph Australia
Anti-depressants, women's answer to Viagra Times of India
all 17 news articles >>      Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?

Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.